NPI: 1073010518 · CONWAY, AR 72032 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/11/2018
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 04/11/2018 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 1,284 | $9K |
| 2020 | 6,660 | $50K |
| 2021 | 1,468 | $22K |
| 2022 | 3,449 | $42K |
| 2023 | 4,856 | $55K |
| 2024 | 2,017 | $33K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 10,718 | 900 | $144K |
| 83970 | 215 | 196 | $21K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,424 | 378 | $14K |
| 82108 | 42 | 39 | $11K | |
| A4657 | Syringe, with or without needle, each | 330 | 298 | $6K |
| 82728 | 105 | 90 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 40 | 38 | $3K |
| 83540 | 109 | 90 | $3K | |
| 83550 | 75 | 64 | $2K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 618 | 65 | $905.28 |
| 85041 | 228 | 195 | $305.64 | |
| 85048 | 227 | 194 | $174.78 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 39 | 24 | $0.00 |
| 85045 | 103 | 91 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 461 | 93 | $0.00 |